[1]
Nizamani, M. 2024. Sarcoidosis after Alemtuzumab therapy: Is Alemtuzumab posing a threat to its patients?. Sarcoidosis, Vasculitis and Diffuse Lung Diseases. 41, 4 (Dec. 2024), e2024036. DOI:https://doi.org/10.36141/svdld.v41i4.15873.